Company Overview of F2G Ltd.
F2G Ltd. discovers and develops drugs to treat life threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. F2G Ltd. was founded in 1998 and is based in Manchester, United Kingdom.
Manchester, M30 0LX
Founded in 1998
44 1617 851 270
44 1617 851 273
Key Executives for F2G Ltd.
F2G Ltd. Key Developments
Similar Private Companies By Industry
|PDD Innovations Ltd.||Europe|
|Chroma Therapeutics Ltd.||Europe|
|Core Technologies Ltd.||Europe|
|Burdica Biomedical Limited||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact F2G Ltd., please visit www.f2g.com. Company data is provided by Capital IQ. Please use this form to report any data issues.